Treatment of Stress and Anxiety in MCI/Mild ADRD

Description

The goal of this clinical trial is to test the effectiveness of a computerized anxiety sensitivity treatment (CAST) compared to a health education control (HEC) in older adults with mild cognitive impairment (MCI) or mild Alzheimer's Disease and related dementias (ADRD) and their care partners. The main questions it aims to answer are: 1. Efficacy of CAST in reducing anxiety and related symptoms among those with MCI/mild ADRD 2. Efficacy of CAST in reducing care partner burden among care partners of people living with MCI/mild ADRD 3. Explore treatment mechanisms using a multi-modal assessment battery of anxiety sensitivity and anxiety Participants will complete six in-person visits including a baseline assessment, two intervention sessions, and three follow-up assessments at 1, 3, and 6-months posttreatment. Participants will also complete three weeks of ecological momentary assessments (EMAs) for one week prior to intervention, one week between intervention sessions, and one week after intervention. If there is a comparison group: Researchers will compare CAST to HEC to see if CAST reduces anxiety and related symptoms in older adults with MCI/mild ADRD and care partner burden to a greater degree than HEC.

Conditions

Anxiety, Mild Cognitive Impairment, Alzheimer Disease, Dementia

Study Overview

Study Details

Study overview

The goal of this clinical trial is to test the effectiveness of a computerized anxiety sensitivity treatment (CAST) compared to a health education control (HEC) in older adults with mild cognitive impairment (MCI) or mild Alzheimer's Disease and related dementias (ADRD) and their care partners. The main questions it aims to answer are: 1. Efficacy of CAST in reducing anxiety and related symptoms among those with MCI/mild ADRD 2. Efficacy of CAST in reducing care partner burden among care partners of people living with MCI/mild ADRD 3. Explore treatment mechanisms using a multi-modal assessment battery of anxiety sensitivity and anxiety Participants will complete six in-person visits including a baseline assessment, two intervention sessions, and three follow-up assessments at 1, 3, and 6-months posttreatment. Participants will also complete three weeks of ecological momentary assessments (EMAs) for one week prior to intervention, one week between intervention sessions, and one week after intervention. If there is a comparison group: Researchers will compare CAST to HEC to see if CAST reduces anxiety and related symptoms in older adults with MCI/mild ADRD and care partner burden to a greater degree than HEC.

Treatment of Stress and Anxiety in Mild Cognitive Impairment/Mild Alzheimer's Disease and Related Dementias - RCT

Treatment of Stress and Anxiety in MCI/Mild ADRD

Condition
Anxiety
Intervention / Treatment

-

Contacts and Locations

Tallahassee

Anxiety and Behavioral Health Clinic, Tallahassee, Florida, United States, 32306

Athens

Ohio University, Athens, Ohio, United States, 45701

Columbus

The Ohio State University, Columbus, Ohio, United States, 43210

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patient age 60+
  • * Care partner 18+
  • * Has care partner who will participate ("someone you have a reciprocal relationship with who provides you with emotional or physical support and helps with decision-making. This could be a spouse or significant other, relative, or close friend whom you spend a significant amount of time with.")
  • * Score of 22 or above on the PROMIS-Anxiety short form (patient only)
  • * Score of 5 or above on SSASI (patient only)
  • * Has smartphone or access to Wi-Fi
  • 1. Participant MoCA score is between 17 to 26
  • 2. Participant Memory Complaint Scale score 3 or greater
  • 3. Care partner quick dementia rating scale score between 2 to 12.5
  • * Issues with seeing or hearing that would prevent reading or listening to computer presentations
  • * Medical conditions that would preclude participation in study
  • * Severe mental illness (e.g., schizophrenia, unmedicated bipolar disorder)
  • * Issues with seeing or hearing that would prevent reading or listening to computer presentations
  • * Medical conditions that would preclude participation in study
  • * Severe mental illness (e.g., schizophrenia, unmedicated bipolar disorder)

Ages Eligible for Study

60 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Florida State University,

Study Record Dates

2028-01